Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02895490 · ClinicalTrials.gov registry record · NA

Communication Training in Promoting Employment Retention Among Cancer Patients

A NA study, sponsored by Virginia Commonwealth University.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT02895490: Clinical Trial NA study, sponsored by Virginia Commonwealth University.

NCT02895490 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02895490, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

This randomized clinical trial studies communication training in promoting employment retention among cancer patients. Communication training may improve patient-employer communication and increase the likelihood that cancer patients will remain employed, reduce patients' time away from work, and increase workplace accommodations that enable patients to balance treatment and work.

Primary Outcome

Modify the Perceived Efficacy in Patient-Physician Interactions (PEPPI) to measure patient confidence in talking with their employer. The revised version will focus on patients' level of confidence in discussing employer accommodation and seeking support from their employer. The PEPPI is a brief ten-item measure that asks patients to rate on a Likert scale their confidence in communicating. It is a widely used measure with strong psychometric properties anchored at 5 - "very confident" and 1 - "

Interventions

  • OTHER questionnaire administration
  • OTHER quality-of-life assessment
  • OTHER educational intervention
  • OTHER communication skills training

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2014-01
Est. Completion 2015-10
Phase NA
Virginia Commonwealth University

558 total trials

Why NCT02895490 stopped before completion

NCT02895490 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.

NCT02895490 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02895490 about?

NCT02895490 is a clinical study titled "Communication Training in Promoting Employment Retention Among Cancer Patients". This randomized clinical trial studies communication training in promoting employment retention among cancer patients. Communication training may improve patient-employer communication and increase the likelihood that cancer patients will remain employed, reduce patients' time away from work, and in...

What is the current status of trial NCT02895490?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2014-01. Estimated completion is 2015-10.

What interventions are being tested in trial NCT02895490?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (OTHER), educational intervention (OTHER), communication skills training (OTHER).

Who is sponsoring clinical trial NCT02895490?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02895490's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02895490, the US trial registry maintained by the National Library of Medicine. NCT02895490 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.